Navigation Links
ERT Reports Third Quarter 2010 Results
Date:11/4/2010

, (2) higher costs associated with the ramp up of the RS operations to meet increased demand, (3) integration-related activities, and (4) a higher mix of site support revenue to total revenue as the RS site support revenue has a lower gross margin than services.  Non-GAAP gross margin percentage was 50.0% in the third quarter of 2010 compared to 57.2% for the second quarter of 2010 and 51.6% a year ago.  
  • GAAP operating income margin percentage was 14.6% in the third quarter of 2010 compared to 3.6% for the second quarter of 2010 and 20.7% a year ago.  The second quarter of 2010 was impacted by $3.8 million of acquisition and integration related costs due to the acquisition of RS.  Non-GAAP operating income margin percentage was 21.3% in the third quarter of 2010 compared to 19.7% for the second quarter of 2010 and 20.7% a year ago.  
  • GAAP net income was $3.2 million, or $0.06 per diluted share, in the third quarter of 2010 compared to $0.8 million, or $0.02 per diluted share, in the second quarter of 2010 and $2.8 million, or $0.06 per diluted share, a year ago.  Non-GAAP net income was $5.4 million, or $0.11 per diluted share, in the third quarter of 2010 compared to $4.0 million, or $0.08 per diluted share, in the second quarter of 2010 and $2.8 million, or $0.06 per diluted share, a year ago.  Unfavorable foreign exchange rate movements in the third quarter of 2010 resulted in a negative impact to GAAP and non-GAAP diluted net income per share of approximately $0.03 per diluted share.
  • Cash flow from operations was $6.4 million in the third quarter of 2010, compared to $7.1 million in the second quarter of 2010 and $5.6 million a year ago.
  • Cash and short-term investments totaled $19.4 million at September 30, 2010 compared to $78.8 million on December 31, 2009.  ERT had $21.0 million in debt as of September 30, 2010, down from $23.0 million at June 30, 2010 due
    '/>"/>

  • SOURCE eResearchTechnology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. ThermoGenesis Reports 35 Percent Increase in First Quarter 2011 Revenues, Adds Strategic Advisor and Inks China Distribution Deal With Nanshan Memorial Medical Institute
    2. IRIDEX Reports Improved Third Quarter 2010 Financial Results
    3. Genoptix Reports Operating Results for the Third Quarter and First Nine Months of 2010
    4. Addus HomeCare Reports Third Quarter 2010 Results
    5. Isis Reports Financial Results and Highlights for Third Quarter 2010
    6. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    7. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
    8. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
    9. Cardiogenesis Reports Third Quarter 2010 Results
    10. Dendreon Reports Third Quarter 2010 Financial Results
    11. Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
    (Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... abstracts of studies in its neuroscience and oncology ... the 67 th American Academy of Neurology ... , from April 18-25. The accepted abstracts feature ... in addition to investigational treatments in AbbVie,s pipeline. ...
    (Date:2/26/2015)... MOUNTAIN VIEW, Calif. , Feb. 26, 2015  IRIDEX ... will release its fourth quarter and full year 2014 financial ... 2015.   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, March 5, ... other business developments. Interested parties may access the ...
    Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2
    ... Calif., Jan. 4, 2011 PneumRx, Inc. ( www.pneumrx.com ... and improvements to the treatment of lung disease, today ... capital commitments.  The oversubscribed round was led by Forbion ... venture capital firms from Europe, and also included a ...
    ... 2011 OrbusNeich today announced that the United States Patent ... protection of the company,s Genous endothelial progenitor cell (EPC) capture ... covers a coating on an implantable medical device that has ... matrix are antibodies or antibody fragments that allow for capture ...
    Cached Medicine Technology:PneumRx, Inc. Raises $33 Million in Capital 2PneumRx, Inc. Raises $33 Million in Capital 3OrbusNeich Granted Expanded U.S. Patent of Genous™ Endothelial Progenitor Cell Capture Technology 2
    (Date:2/28/2015)... 28, 2015 How would you ... , There are all kinds of different leaders, ... awareness of the advantages and applications of different ... launching a new product this spring called The ... the connection between personality type, leadership, and success. ...
    (Date:2/28/2015)... 28, 2015 The noted Toronto plastic ... Surgery was recently featured in the January/February 2015 issue ... Dr. David Ellis was featured in an article entitled ... cosmetic enhancements that Kim Cattrall has possibly undergone to ... forehead is smooth without horizontal lines or frown line ...
    (Date:2/28/2015)... February 28, 2015 “ Powermod ” was ... which takes a look at the latest and coolest technology ... reporter for NewsWatch and a technology expert, conducted the review ... of charging solutions. , Getting stuck with a low battery ... a problem that people face on a daily basis. Even ...
    (Date:2/28/2015)... The World Scout League Commission (WSLC), ... potential EMTs and firefighters, recently announced its decision to ... to raise charitable donations for age-related research. The five-kilometer ... be held on March 29, 2015; registration will start ... 3:30 p.m. , To participate in the race, ...
    (Date:2/27/2015)... Sacramento, Calif. (PRWEB) February 27, 2015 ... of liver-disease death, between four and 12 years earlier ... study from UC Davis Health System. , While previous ... ALD than other populations, the new study -- published ... -- is believed to be the first to pinpoint ...
    Breaking Medicine News(10 mins):Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:Bitcoin Run Is The World Scout League Commission’s Newest Project for Charity 2Health News:UC Davis Study Finds Hispanics Develop Alcoholic Liver Disease at Younger Ages than Caucasians or African Americans 2
    ... University of North Carolina at Chapel Hill have launched a ... help prevent depression and cardiovascular illness in women between the ... may raise eyebrows in some quarters, given that a Women,s ... findings that estrogen therapy resulted in an increased risk of ...
    ... geneticist Pier Paolo Pandolfi, MD, PhD, is the recipient ... Research) International Award for Cancer Research. This is the ... BIDMC investigator has received this prestigious honor, which was ... renown who has made a major scientific discovery in ...
    ... the Peninsula College of Medicine and Dentistry are part of ... implement a 4.7m Policy Research Unit dedicated to achieving early ... years by the Department of Health and will be led ... the project include Barts and the London School of Medicine ...
    ... , WEDNESDAY, Jan. 12 (HealthDay News) -- Even though ... understand many spoken words and use the same brain structures ... The findings challenge the widely held belief that infants ... words, and that this ability begins primitively and evolves into ...
    ... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- Over ... blood pressure drug candesartan stood a higher chance of survival ... fact, 61 percent of those taking candesartan (Atacand) survived, compared ... may be due to differences in the way the drugs ...
    ... Use of an artery from the arm rather than a ... coronary artery bypass graft (CABG) patients, according to a new ... means that the graft is open and unobstructed -- in ... arm,s radial artery was used in 366 patients and the ...
    Cached Medicine News:Health News:UNC researchers investigate estrogen to prevent depression and cardiovascular disease 2Health News:Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research 2Health News:Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research 3Health News:Funding to improve cancer survival rates 2Health News:Infants Process Words Much Like Adults, Study Finds 2Health News:Not All Heart Failure Drugs Boost Survival Equally 2
    ... of Vision and Contrast Sensitivity. The ... and glare luminance levels for accurate ... with/without glare and background luminance Comply ... standards. All Light Levels Microprocessor Controlled ...
    ... profitability by reducing ... simple test,sequences that ... by ancillary office ... 5 minutes. New ...
    Holladay Contract Acuity Test provides a more sensitive evaluation for testing visual functions than standard acuity charts....
    Vectograms are the standard for vision training. They are available in fixed or variable,styles to accommodate unlimited base-in and base-out training. Each vectogram,includes one pair,of standard 3-...
    Medicine Products: